Featured Research

from universities, journals, and other organizations

DNA Research Highlights Prostate Cancer Mechanisms

Date:
April 12, 2004
Source:
National Institute Of Standards And Technology
Summary:
Certain prostate cancer cell lines are unable to repair DNA damage caused by "free radicals," according to scientists at the National Institute of Standards and Technology (NIST) and National Institutes of Health (NIH).

Certain prostate cancer cell lines are unable to repair DNA damage caused by "free radicals," according to scientists at the National Institute of Standards and Technology (NIST) and National Institutes of Health (NIH). This type of damage has been implicated before in the development of prostate cancer, but the new research, described in the March 25 online edition of Carcinogenesis, provides the first solid evidence that the normal repair process is altered in prostate cancer cells, possibly leading to a cascade of events that culminate in further DNA damage and cellular dysfunction.

Free radicals—highly reactive molecules generated by both normal metabolism and external sources such as chemicals and ionizing radiation—produce more than 30 different types of lesions in the nitrogen-containing compounds or "bases" of DNA. The damage is generally repaired in normal cells of young, healthy people. The NIH/NIST study examined four types of lesions in DNA from both cell nuclei and mitochondria, the energy factories of cells. The scientists found that prostate cancer cells unexposed to ionizing radiation had high levels of free radical damage and defective repair mechanisms. They also found that, after exposure to ionizing radiation and a repair period, prostate cancer cells exhibited elevated levels of free radical damage and reduced removal of lesions.

Prostate cancer is the most common form of cancer among American men. The new findings may help to explain the molecular mechanisms underlying the disease and support the idea that free radical damage and repair are "critical factors" in its development. The findings also have implications for possible therapies, supporting the theory, for instance, that selenium—a trace element that is a constituent of antioxidant enzymes—may be useful in preventing prostate cancer.

NIST's primary role in the study was to measure the types and levels of DNA damage. NIST pioneered the development of methods for detecting and measuring free radical damage at levels less than one base per million bases. The research was led by the National Institute on Aging.


Story Source:

The above story is based on materials provided by National Institute Of Standards And Technology. Note: Materials may be edited for content and length.


Cite This Page:

National Institute Of Standards And Technology. "DNA Research Highlights Prostate Cancer Mechanisms." ScienceDaily. ScienceDaily, 12 April 2004. <www.sciencedaily.com/releases/2004/04/040412012907.htm>.
National Institute Of Standards And Technology. (2004, April 12). DNA Research Highlights Prostate Cancer Mechanisms. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2004/04/040412012907.htm
National Institute Of Standards And Technology. "DNA Research Highlights Prostate Cancer Mechanisms." ScienceDaily. www.sciencedaily.com/releases/2004/04/040412012907.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins